Related Articles
Clinical relevance of Cyr61 expression in patients with hormone-dependent breast cancer
ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients
Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
Different survival determinants of metastatic breast cancer patients treated with endocrine therapy or chemo-endocrine therapy.
Male breast cancer: Specific biological characteristics and survival in a Portuguese cohort